Burning Rock Announces Publication of Registration Document and Possible Direct Listing on the London Stock Exchange

Enter Wall Street with StreetInsider Premium. Claim your one week free trial here.

NOT TO BROADCAST, PUBLISH OR DISTRIBUTE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR FROM AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION WOULD BE ILLEGAL .

BURNING ROCK BIOTECH LIMITED – Proposed direct listing on the London Stock Exchange and publication of the registration document

October 21, 2022

Neither this announcement, nor anything contained herein, nor anything contained in the registration document (the “Registration Document”) referred to herein shall form the basis of, or be relied upon in connection with, any offer or undertaking in any jurisdiction. Investors must not subscribe for or purchase the securities referred to in this press release or in the Registration Document, except on the sole basis of the information contained in a prospectus in its final form (together with any additional prospectus, if any, the “Prospectus”), including the risk factors set out therein which may be published in due course in connection with the possible admission of the Company’s American Depositary Shares (the “ADS”) to the listing segment FCA Official List Standard and trading on the Main Market of the London Stock Exchange plc (the “London Stock Exchange”) through a direct listing.

A copy of any Prospectus will, if published by the Company, be submitted to the FCA’s national storage mechanism and available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism and made available on the Company’s website. website at http://ir.brbiotech.com subject to certain access restrictions.

LONDON, Oct. 21, 2022 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on applying next-generation sequencing technology ( NGS) in the precision oncology field, announces that, following its press release dated June 21, 2022, it has applied for admission of ADSs to the standard listing segment of the FCA’s official list and to trading on the main market of the London Stock Exchange (the “LSE”) by means of a direct listing (the “Direct Listing”).

Burning Rock has prepared a Direct Entry registration document which has been approved by the FCA. A copy of the registration document has been submitted to the FCA National Storage Mechanism and will be available for inspection at the following link: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

A copy of the Registration Document will also be available online on the Company’s website at http://ir.brbiotech.com.

If direct listing continues, Burning Rock’s ADSs are expected to continue to be listed and traded on the Nasdaq Global Market, such ADSs being fully fungible with the LSE-listed ADSs. Custody and depositary links will be established between Euroclear, Clearstream and DTC to facilitate cross-market transfers of ADS associated with secondary market trading.

About Burning Rock

Burning Rock Biotech Limited (NASDAQ: BNR), whose mission is to protect life through science, focuses on the application of next-generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection tests for advanced-stage cancer patients, and ii) early cancer detection, which has moved from proof-of-concept R&D to clinical validation step.

For more information on Burning Rock, please visit: www.brbiotech.com.

Requests:

Contact: [email protected]

Important legal information

The information in this announcement is provided for informational purposes only and does not purport to be comprehensive or complete, and this announcement does not constitute or form part of an invitation or inducement to engage in investment activity. No reliance can be placed by anyone for any purpose on the information contained in this announcement or on its accuracy, fairness or completeness. The content of this announcement should not be construed as legal, financial or tax advice.

This announcement is not intended for broadcast, publication or distribution, directly or indirectly, in Australia, Canada, South Africa or Japan or in any other jurisdiction where, or to anyone to whom, doing so would constitute violation of applicable law. or regulation.

These materials do not constitute or form part of any offer or invitation to sell or issue, nor any solicitation of any offer to purchase or subscribe for, ADS or any other security, nor (or any part thereof -it), or the fact of its distribution, form the basis of, or be invoked in connection with, any contract therefor.

This announcement may include forward-looking statements, which are based on current expectations and projections of future events. Such statements may include, but are not limited to, any statement preceded, followed by, or including words such as “target”, “believe”, “expect”, “aim”, “intend”, ” can”, “anticipate”, “estimate”. “, “plan”, “project”, “will”, “may have”, “probable”, “should”, “would”, “could” and any other word or term having a similar meaning or its negative form. These forward-looking statements are subject to risks, uncertainties and assumptions about Burning Rock and its subsidiaries. In light of these risks, uncertainties and assumptions, the events described in the forward-looking statements may not occur. Past performance cannot be taken as an indication of future performance and should not be taken as a representation that the trends or activities underlying past performance will continue in the future. No representation or warranty is or will be made that any forward-looking statement will occur. The forward-looking statements contained in this announcement speak only as of the date of this announcement.

Burning Rock expressly disclaims any obligation or undertaking to update, review or revise any forward-looking statements contained in this announcement and disclaims any obligation to update its view of the risks or uncertainties described herein or to publicly announce the results of any revisions to forward-looking statements. – forward-looking statements made in this announcement, whether as a result of new information, future developments or otherwise, except as required by law.

The information in this announcement is subject to change. Persons viewing this announcement should ensure that they fully understand and accept the risks which will be set out in the Prospectus, if published.

Unless otherwise stated, market, industry and competitive position data are estimates (and therefore, approximate) and should be treated with caution. This information has not been independently audited or verified, and the Group has not verified the underlying economic assumptions on which it is based. Certain data in this announcement, including financial, statistical and operational information, has been rounded. Due to rounding, the totals of the data presented in this announcement may differ slightly from the actual arithmetic totals of these data.

For the avoidance of doubt, material from the Company’s website is not incorporated by reference into, and does not form part of, this announcement.